Detalhe da pesquisa
1.
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
Int J Gynecol Pathol
; 43(2): 123-133, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37406366
2.
Histopathological examination of the ectocervical biopsy in non-transplanted uteri: A study contributing to the provisional scoring system of subclinical graft rejection after uterus transplantation.
Acta Obstet Gynecol Scand
; 101(1): 37-45, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34693986
3.
Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.
Cytopathology
; 30(5): 510-518, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30943322
4.
Clinical and cytopathological factors affecting the cellularity of urinary cell blocks and the implication for diagnosis and follow-up of urinary bladder urothelial carcinoma.
Cytopathology
; 29(6): 537-544, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29873845
5.
Intraoperative consultation in gynecologic pathology.
Cesk Patol
; 54(3): 105-118, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30445815
6.
Concordance of HPV-DNA in cervical dysplasia or genital warts in women and their monogamous long-term male partners.
J Med Virol
; 89(9): 1662-1670, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28390162
7.
[BRCA1 and BRCA2 - pathologists starting kit]. / BRCA1 a BRCA2 - patologuv startovní balícek.
Cesk Patol
; 52(4): 193-196, 2016.
Artigo
Tcheco
| MEDLINE | ID: mdl-27869444
8.
[Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum]. / Onkopatologické aspekty inaktivace genu BRCA1 a BRCA2 v nádorech ovaria, delozní tuby a pánevního peritonea.
Cesk Patol
; 52(4): 199-204, 2016.
Artigo
Tcheco
| MEDLINE | ID: mdl-27869446
9.
Review of neoadjuvant chemotherapy and trachelectomy: which cervical cancer patients would be suitable for neoadjuvant chemotherapy followed by fertility-sparing surgery?
Curr Oncol Rep
; 17(5): 446, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25893880
10.
Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer.
Gynecol Oncol
; 135(2): 213-6, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25159484
11.
Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas.
J Mol Diagn
; 26(4): 257-266, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38280423
12.
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Nat Commun
; 15(1): 2528, 2024 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38514660
13.
High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer.
Gynecol Oncol
; 128(1): 49-53, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23063763
14.
Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.
Virchows Arch
; 483(4): 509-516, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37610627
15.
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
Virchows Arch
; 483(4): 497-507, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37676270
16.
A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Diagn Pathol
; 18(1): 32, 2023 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36855066
17.
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Diagn Pathol
; 18(1): 15, 2023 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36740684
18.
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Diagn Pathol
; 18(1): 72, 2023 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37303048
19.
Surgical options in early cervical cancer.
Int J Hyperthermia
; 28(6): 489-500, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22690735
20.
Fertility-sparing surgery in patients with cervical cancer.
Lancet Oncol
; 12(2): 192-200, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20619737